Product Information
RISPERIDONE 3 MG TABLET is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.0686 per EA under NDC 68382011605. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Oct 16, 2008. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
3 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
68382011605
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
RISPERIDONEApproval Type
Generic (ANDA)
FDA Application
ANDA078040FDA Approved
10/16/2008
TE Code
AB
On Market Since
11/13/2008
Pharmacological Classes
Price Statistics
The NADAC for RISPERIDONE 3 MG TABLET has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 47.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0686 per EA |
|---|---|
| All-time high | $0.1754 (Feb 12, 2014) |
| All-time low | $0.0512 (May 22, 2024) |
| 52-week high | $0.0710 |
| 52-week low | $0.0644 |
| Median price | $0.0694 |
| Average price | $0.0803 |
| Largest weekly change | -27.7% (Apr 17, 2024) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Zydus Pharmaceuticals (USA) Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
risperidone market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Atypical Antipsychotic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of RISPERIDONE 3 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for RISPERIDONE 3 MG TABLET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.0686 per EA (NDC 68382011605), effective Sep 30, 2026.
How has the price of RISPERIDONE 3 MG TABLET changed over time?
Over the history we have for it, the NADAC for RISPERIDONE 3 MG TABLET has declined 47.8%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for RISPERIDONE 3 MG TABLET?
Since Nov 28, 2013, the NADAC for RISPERIDONE 3 MG TABLET has ranged from a low of $0.0512 (May 22, 2024) to a high of $0.1754 (Feb 12, 2014), with a median of $0.0694 per EA.
Are there cheaper alternatives to RISPERIDONE 3 MG TABLET?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as RISPERIDONE 3 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures RISPERIDONE 3 MG TABLET?
RISPERIDONE 3 MG TABLET (NDC 68382011605) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.